Anuh Pharma Ltd
Anuh Pharma Ltd Company History
Anuh Pharma is engaged in the business of manufacturing and selling of “Bulk drugs and chemicals”.
2006
In early January, the promoters sold off nearly 14.9% of their stake in the company.
Anuh Pharma has given the Bonus in the Ratio of 1:1
Company has splits its Face value of Shares from Rs 10 to Rs 5
2006
2010
Anuh Pharma has given the Bonus in the Ratio of 2:1
2010
2011
Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00.
2011
2012
Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory.
Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00.
2012
2013
Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00.
2013
2014
Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate.
Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share.
2014
2015
The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1.
2015
2016
Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France.
2016
2020
The Company has issued Bonus Shares in the Ratio of 1:1.
2020
